APA (7th ed.) Citation

K, A., S, D., O, K., V, Y., & S, J. (2025). Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer. Drug delivery and translational research, 15(12), 4550. https://doi.org/10.1007/s13346-025-01833-9

Chicago Style (17th ed.) Citation

K, Abhang, Dighe S, Katari O, Yadav V, and Jain S. "Dual Acting Oxaliplatin (IV) Prodrug Loaded Albumin Nanoparticles for Safer Synergistic Anticancer Action Against Triple Negative Breast Cancer." Drug Delivery and Translational Research 15, no. 12 (2025): 4550. https://doi.org/10.1007/s13346-025-01833-9.

MLA (9th ed.) Citation

K, Abhang, et al. "Dual Acting Oxaliplatin (IV) Prodrug Loaded Albumin Nanoparticles for Safer Synergistic Anticancer Action Against Triple Negative Breast Cancer." Drug Delivery and Translational Research, vol. 15, no. 12, 2025, p. 4550, https://doi.org/10.1007/s13346-025-01833-9.